Warren Eric

Number of records: 18
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
15-Mar-24 4:35 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 14-Mar-24Grant 100,000----146%
68.32K to 168.32K
21-Sep-23 5:06 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 20-Sep-23Sale 742$1.25$923.79(1%)
69.06K to 68.32K
21-Aug-23 4:32 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 18-Aug-23Sale 243$1.41$343.60(< 1%)
69.3K to 69.06K
20-Jul-23 4:38 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 19-Jul-23Sale 106$1.59$168.01(< 1%)
69.41K to 69.3K
22-Jun-23 4:45 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 21-Jun-23Sale 603$1.48$894.25(< 1%)
70.01K to 69.41K
18-May-23 4:07 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 17-May-23Sale 219$1.62$355.66(< 1%)
70.23K to 70.01K
20-Apr-23 4:12 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 19-Apr-23Sale 115$1.28$146.97(< 1%)
70.35K to 70.23K
20-Mar-23 4:16 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 17-Mar-23Sale 526$1.78$937.49(< 1%)
70.87K to 70.35K
15-Mar-23 9:22 AM
View: 
Esperion Therapeutics, Inc. (ESPR) 14-Mar-23Grant 22,300----46%
48.57K to 70.87K
08-Mar-23 4:22 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 07-Mar-23Private Sale 5,090$5.05$25,729.90(9%)
53.66K to 48.57K
19-Oct-22 4:11 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 18-Oct-22Private Sale 107$7.69$822.83(< 1%)
53.77K to 53.66K
20-Sep-22 4:09 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 19-Sep-22Private Sale 255$6.92$1,764.85(< 1%)
54.02K to 53.77K
31-Aug-22 4:14 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 31-Aug-22Purchase 1,000$7.46$7,460.002%
53.02K to 54.02K
18-Aug-22 4:10 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 17-Aug-22Private Sale 199$6.82$1,356.19(< 1%)
53.22K to 53.02K
20-Jul-22 4:27 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 19-Jul-22Private Sale 431$6.58$2,836.84(< 1%)
53.65K to 53.22K
21-Jun-22 4:06 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 17-Jun-22Private Sale 256$4.90$1,254.40(< 1%)
53.91K to 53.65K
18-May-22 4:30 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 17-May-22Private Sale 196$5.98$1,172.28(< 1%)
54.11K to 53.91K
16-Mar-22 5:11 PM
View: 
Esperion Therapeutics, Inc. (ESPR) 14-Mar-22Grant 13,000----32%
41.11K to 54.11K